Stockscreener 앱 받기
2.68
0.00%
0.00
시간 외 거래:
2.79
0.11
+4.10%
Adc Therapeutics Sa 주식(ADCT)의 최신 뉴스
Can ADC Therapeutics SA weather a recessionConsistent Triple Digit Profits - mustnews.co.kr
Using data models to predict ADC Therapeutics SA stock movementPortfolio Positioning Strategy With Timing - Newser
How to recover losses in ADC Therapeutics SA stockSafe Entry Screening with Data Backed Analysis - Newser
Can volume confirm reversal in ADC Therapeutics SASwing Trade Timing with Daily Forecast - Newser
Will ADC Therapeutics SA stock go up soonWeekly Hot Stocks Based on Volume Flow - Newser
Will ADC Therapeutics SA continue its uptrendFree Value Investing Picks With Stability - Newser
Pattern recognition hints at ADC Therapeutics SA upsideAlpha Trade Flow With Risk Calibration - Newser
Earnings visualization tools for ADC Therapeutics SAFree Weekly Return Pick Forecast Reports - Newser
Is ADC Therapeutics SA reversing from oversold territoryRSI and MACD Signal Summary with Trends - Newser
Bank of New York Mellon Corp Decreases Stock Holdings in ADC Therapeutics SA (NYSE:ADCT) - Defense World
ADC Therapeutics to Host Second Quarter 2025 Financial Results Conference Call on August 12, 2025 - BioSpace
What’s next for ADC Therapeutics SA stock pricePredictive Analytics for Equity Growth Potential - Newser
Are Medical Stocks Lagging ADC Therapeutics (ADCT) This Year? - sharewise.com
What makes ADC Therapeutics SA stock price move sharplySmart Trade Mapping with Entry Details - Newser
Chondrosarcoma Market: Epidemiology, Pipeline Products, Companies Working, Delveinsight Aadi Bioscience Inc, Acrotech Biopharma LLC, ADC Therapeutics SA, Advenchen Laboratories LLC, Alkermes Plc, As - Menafn
How strong is ADC Therapeutics SA company’s balance sheetCapitalize on emerging growth stocks - Jammu Links News
What is ADC Therapeutics SA company’s growth strategyGet alerts on high-potential stock breakouts - Jammu Links News
How volatile is ADC Therapeutics SA stock compared to the marketMaximize portfolio value with expert tips - Jammu Links News
Does ADC Therapeutics SA stock perform well during market downturnsGet daily updates on top-performing stocks - Jammu Links News
Should I hold or sell ADC Therapeutics SA stock in 2025Achieve rapid growth with smart investments - Jammu Links News
What institutional investors are buying ADC Therapeutics SA stockConsistent triple-digit returns - Jammu Links News
What is the dividend policy of ADC Therapeutics SA stockUnlock exclusive trading strategies for gains - Jammu Links News
ADC Therapeutics (ADCT) to Release Quarterly Earnings on Tuesday - Defense World
Is ADC Therapeutics SA stock overvalued or undervaluedGet daily updates on promising stocks - Jammu Links News
Why ADC Therapeutics SA stock attracts strong analyst attentionEquity Forecast with Predictive AI Screener - Newser
How does ADC Therapeutics SA generate profit in a changing economyLightning-fast growth - Jammu Links News
What are the latest earnings results for ADC Therapeutics SAInvest smarter with actionable trading signals - Jammu Links News
What are ADC Therapeutics SA company’s key revenue driversUnlock high-yield investment opportunities - Jammu Links News
What is the risk reward ratio of investing in ADC Therapeutics SA stockAchieve rapid capital gains with smart investing - Jammu Links News
Earnings Beat: ADC Therapeutics SA (NYSE:ADCT) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts - 富途牛牛
ADC Therapeutics (ADCT) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
Adc Therapeutics shares rise 11.52% after-hours after granting options to new employees. - AInvest
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan - StreetInsider
ADC Therapeutics Makes Grants To New Employees Under Inducement Plan - Barchart.com
ADC Therapeutics SA expected to post a loss of 47 cents a shareEarnings Preview - TradingView
How ADC Therapeutics SA stock performs during market volatilityTarget Return Focused Trade Insights Shared - metal.it
ADC Therapeutics SA Price Targets Raised After ReboundWeekly Watchlist of High Movers Released - metal.it
ADC Therapeutics SA Breaks Losing Streak — Is the Trend ReversingTrade Setups With Clear Risk Limits Highlighted - beatles.ru
Sectors Driving Future Growth for ADC Therapeutics SA StockNeural Network Based Equity Prediction System - Newser
Neuroendocrine Tumors Clinical Trials, Companies, - openPR.com
Neuroendocrine Tumors Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline Analysis | RayzeBio, Inc., Seneca Therapeutics, Vyriad, Inc., ADC Therapeutics, Eli L - Barchart.com
ADC Therapeutics SA Shows Risk Reward Favoring UpsideExit Ready Momentum Stock Watchlist Expanded - metal.it
1.02%
3.70%
자본화:
|
볼륨(24시간):